Status:

COMPLETED

More Than a Machine: Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV-1-infection

Eligibility:

All Genders

18+ years

Brief Summary

This is a two-phase study designed to assess measures of feasibility, sustainability, acceptability, penetration, and fidelity before and after implementation of a rapid molecular HIV-1 viral load tes...

Detailed Description

This is a two-phase study designed to assess measures of feasibility, sustainability, acceptability, penetration, and fidelity before and after implementation of a rapid molecular HIV-1 viral load tes...

Eligibility Criteria

Inclusion

  • Adult patients aged 18 years or older receiving care at the Bugoye Health Center Antiretroviral therapy clinic

Exclusion

  • Patients unwilling or unable to provide informed consent

Key Trial Info

Start Date :

August 8 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2021

Estimated Enrollment :

242 Patients enrolled

Trial Details

Trial ID

NCT04517825

Start Date

August 8 2020

End Date

June 30 2021

Last Update

May 23 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Bugoye Level III Health Centre

Bugoye, Kasese, Uganda

2

Mbarara University of Science and Technology (MUST)

Mbarara, Uganda, PO Box 1410